Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings

• Published in: Molecular biology reports Vol. 48; no. 3; pp. 2025 - 2033
• Main Authors: Arpacı, Abdullah, Doğan, Serdar, Erdoğan, Hazal Fatma, El, Çiğdem, Cura, Sibel Elmacıoğlu
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.03.2021; Springer Nature B.V
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Animal Anatomy; Animal Biochemistry; Arthritis; Biomedical and Life Sciences; Child; Child, Preschool; Erysipelas; Familial Mediterranean fever; Familial Mediterranean Fever - genetics; Female; Fever; Genetic Predisposition to Disease; Histology; Humans; Infant; Infant, Newborn; Life Sciences; Male; Middle Aged; Minority & ethnic groups; Morphology; Mutation; Mutation - genetics; Mutation Rate; Nucleotide sequence; Original; Original Article; Patients; Peritonitis; Pleurisy; Point mutation; Pyrin - genetics; Pyrin protein; Sequence analysis; Young Adult; R202Q; Tel Hashomer criteria; FMF
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-020-06040-y

Familial Mediterranean Fever (FMF), which is an autosomal recessive disease characterized by recurrent self-limiting fever, peritonitis, pleuritis, arthritis and erysipelas-like erythemas, has been common among ethnic groups such as Turkish, Armenian, Arabic and Jewish. The clinical presentation is caused by mutations in the MEFV gene encoding the Pyrin protein. In this study, we aimed to present a new mutation that has not been previously defined from the mutations in the MEFV gene which is responsible for the genetic pathology of familial Mediterranean fever and to evaluate the frequency of distribution of the MEFV gene mutation among different ethnic groups living in our region. In present retrospective study, a total of 2639 clinically suspected FMF patients who were referred to Hatay Mustafa Kemal University Hospital between 2010 and 2017 were recorded. MEFV gene mutations were observed using DNA sequence analysis. MEFV mutations were found in 2079 of the 2639 patients (78.7%) Among these patients 184 (6.97%) were homozygous, while 1365 (51.72%) were heterozygous. The most frequently observed mutation was R202Q (1319, 19.55%) followed by E148Q (n = 476, 7.05%), M694V (n = 439, 6.51%), V726A (n = 146, 2.16%) and M680I (n = 135, 2%). In a case clinically diagnosed as FMF, a new mutation called S145G (p. Ser145Gly, c.433A > G) was identified in exon 2 of the MEFV gene. Besides, addition of a new pathogenic MEFV variant to the literature, the relationship between the FMF clinic and homozygous form of R202Q, which was previously considered as a polymorphism, was highlighted.